361 related articles for article (PubMed ID: 23832659)
1. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
Simonella L; Canfell K
Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Australian National Cervical Screening Program in women of different ages.
Smith M; Canfell K
Med J Aust; 2016 Oct; 205(8):359-364. PubMed ID: 27736623
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer.
Beral V; Hermon C; Muñoz N; Devesa SS
Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer in New Zealand: national and regional trends.
Cox B; Borman B
N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer incidence and mortality in Fiji 2003-2009.
Kuehn R; Fong J; Taylor R; Gyaneshwar R; Carter K
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):380-6. PubMed ID: 22861663
[TBL] [Abstract][Full Text] [Related]
6. Commentary on "Cervical cancer screening in England: the past, present, and future": a comparison with Canada.
Duggan MA
Cancer Cytopathol; 2012 Apr; 120(2):97-101. PubMed ID: 22367793
[TBL] [Abstract][Full Text] [Related]
7. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
Taylor R; Morrell S; Mamoon H; Wain G; Ross J
Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
[TBL] [Abstract][Full Text] [Related]
8. Cancer mortality and incidence trends comparing New Zealand and Australia for the period 2000-2007.
Alafeishat L; Elwood M; Ioannides S
N Z Med J; 2014 Aug; 127(1400):9-19. PubMed ID: 25145363
[TBL] [Abstract][Full Text] [Related]
9. Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985-2013 in all women and in Māori women.
Smith MA; Edwards S; Canfell K
Cancer Causes Control; 2017 Dec; 28(12):1393-1404. PubMed ID: 28986722
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
11. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
12. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
[TBL] [Abstract][Full Text] [Related]
13. What happens when organization of cervical cancer screening is delayed or stopped?
Lynge E; Clausen LB; Guignard R; Poll P
J Med Screen; 2006; 13(1):41-6. PubMed ID: 16569305
[TBL] [Abstract][Full Text] [Related]
14. The cervical cancer epidemic that screening has prevented in the UK.
Peto J; Gilham C; Fletcher O; Matthews FE
Lancet; 2004 Jul 17-23; 364(9430):249-56. PubMed ID: 15262102
[TBL] [Abstract][Full Text] [Related]
15. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.
de Blasio BF; Neilson AR; Klemp M; Skjeldestad FE
J Public Health (Oxf); 2012 Dec; 34(4):539-47. PubMed ID: 22707556
[TBL] [Abstract][Full Text] [Related]
16. [The significance of organized screening for uterine cervix cancer in Denmark during 1968-1987].
Lynge E; Engholm G; Madsen M
Ugeskr Laeger; 1992 May; 154(19):1330-4. PubMed ID: 1598705
[TBL] [Abstract][Full Text] [Related]
17. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
18. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
Vaccarella S; Lortet-Tieulent J; Plummer M; Franceschi S; Bray F
Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years.
Creighton P; Lew JB; Clements M; Smith M; Howard K; Dyer S; Lord S; Canfell K
BMC Public Health; 2010 Nov; 10():734. PubMed ID: 21110881
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cancer survival in New Zealand and Australia, 2006-2010.
Aye PS; Elwood JM; Stevanovic V
N Z Med J; 2014 Dec; 127(1407):14-26. PubMed ID: 25530328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
